The expression levels of CD3, CD14, and CD20 on the surface of MDS-L cells increased after DAC treatment, accompanied by antigen changes, with CD13 showing a significant decrease after treatment, while the expression of CD235a showed no obvious change during DAC treatment. Here, GYPA is linked to myelodysplastic syndrome.